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or sibutramine (10mg/d) in a randomized, controlled, single-
blind clinical study, and evaluated weight and satisfaction during
six-weeks of this treatment. RESULTS: A total of 40 females 36
+/- 4yr with orlistat; and 40 females, aged 37 +/- 6yr with sibu-
tramine) completed six-weeks on exercise and a controlled-
energy diet. Orlistat was well tolerated, with gastrointestinal
adverse effects as well as inhibiting the assimilation of fat from
the bowel. It was approved for long-term treatment of obesity
while sibutramine acted on the cns to control appetite or enhance
the feeling of saturation. Signiﬁcant body mass index (bmi)
improvement was detected after six-weeks (p < 0.05) in both
groups (p = 0.02, p = 0.04 respectively). Signiﬁcant waist cir-
cumference (wc), but not signiﬁcant hip circumference (hc),
improvement were observed in both groups (p = 0.03, p = 0.14,
p = 0.04, p = 0.21 respectively). Orlistat and sibutramine were
not signiﬁcantly different in terms of weight reduction effect (p
= 0.14). However, patients were more satisﬁed with oristat than
sibutramine (p = 0.02). CONCLUSIONS: Orlistat and sibu-
tramine could signiﬁcantly reduce weight. However, patients
were more satisﬁed with orlistat than sibutramine.
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OBJECTIVE: Patterns of obesity are an important public health
consideration. The purpose of this study was to determine the
past and future population trends of obesity in the UK (UK).
METHODS: Data describing body mass index (BMI) were
abstracted from the English Health Survey’s from 1991 to 2002,
inclusive. The UK was assumed to follow the same pattern of
change in body composition as England. The distributional
pattern of BMI was determined and age and sex speciﬁc changes
in the distribution described over the period. Data were stan-
dardized to the UK population in 2001. Ethnicity was accounted
for in the forecast using general linear models for age and sex
speciﬁc groups applied to government forecasts of future demog-
raphy. RESULTS: BMI increased by a mean value of 1.21kg/m2
(standard error of the mean (SEM) 0.105 to 0.044 [≥18 years]),
equivalent to an annual increase of 0.11kg/m2 per year (95% CI
0.106 to 0.123). BMI in women increased on average from 25.6
to 26.8kg/m2, and men’s from 25.9 to 27.1kg/m2. This varied
by age and sex. The annual change in mean BMI was linear in
every age group. In 1991 and 2002 the proportion of overweight
(≥25.0 to <30.0kg/m2) and obese (≥30.0kg/m2) people in the
population rose from 29.5% and 12.0%, to 31.3% and 18.4%,
respectively. The number of overweight and obese people in the
general population in 2004 was estimated to be 31.2 million
people (52.6%), increasing to 38.0 million people (62.0%) in ten
years time, an increase of 6.8 million people. CONCLUSION: If
reliable, this estimate clearly represents a serious public health
challenge.
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OBJECTIVES: To assess epidemiologic trends of overweight and
obesity and to examine treatment patterns to control weight in
children/adolescents aged 2–19 years and for adults ≥20 years
old. METHODS: The Third National Health and Nutrition
Examination Survey (NHANES III) conducted in 1988–1994
and NHANES 2001–2002 were used. Children/adolescents 
were classiﬁed as at risk for overweight if body mass index (BMI)
was ≥85th–<95th percentile and as overweight if BMI was at
≥95th percentile of the sex-speciﬁc BMI for age growth charts.
Adults were categorized as overweight (BMI 25.0–29.9) or obese
(BMI ≥ 30.0). Duration of physical activity was calculated 
using leisure-time physical activity to assess compliance of
CDC/ASCM recommendations. SAS and SUDAAN software
were employed to account for the complex survey design.
RESULTS: The proportions of children/adolescents at risk for
overweight or overweight increased from 13.1% to 14.5% 
and from 11.1% to 15.5%, respectively, between 1988–1994
and 2001–2002. The prevalence of overweight and obesity for
adults also increased from 32.8% to 35.2% and from 22.3% to
30.2%. Prevalence of diabetes in overweight and obese adults
slightly increased between 1988–1994 (5.5%, 10.0% respec-
tively) and 2001–2002 (6.1%, 10.6%). However, LDL ≥ 130
mg/dL was less prevalent in 2001–2002 (53.4% to 41.8% 
for overweight and 54.0% to 41.0% for obesity). Overall,
10.3% of overweight and 14.9% of obese adults used liquid diet
formula, prescription drugs, non-prescription drugs, laxatives or
vomiting to control weight in 2001–2002. Only 1% of over-
weight and 3% of obese adults took prescribed diet pills. About
47% of overweight and 43% of obese adults either took med-
ications or complied with physical activity recommended by
CDC/ASCM to control weight. CONCLUSIONS: Overweight
and obesity have become more prevalent in the US population
during the past decade. However, very few patients took med-
ications prescribed by their physicians to lose or control their
weight.
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BMI is widely used to measure obesity in outcome studies, but
other easily collected measures are available to characterise
bodily shape. OBJECTIVE: The objective of this study was to
determine whether BMI and waist-to-hip ratio (W:H-R), as stan-
dard measures of obesity, collectively better explained the likeli-
hood of obesity-related complications. METHODS: This
retrospective study used data from the England Health Survey, a
national representative survey of the general population. Data
describing BMI, obesity related diseases and other anthropo-
metric measurements were abstracted from the survey 1991 to
1994, and 1997 to 2002. Using this data, a model was devel-
oped to account for various factors that could effect the devel-
opment of obesity related diseases: diabetes, stroke, heart attack,
hypertension and other vascular diseases. Using logistic regres-
sion, the association of between BMI categories further broken
down by W:H-R categories was determined. The results were
standardized for age, sex and ethnicity to generate standardized
odds ratios comparing the accuracy of different anthropometric
measurements and its combinations to predict obesity related
diseases. RESULTS: BMI and W:H-R were independent predic-
tors of disease in obesity. Using both these measures a more
precise prediction of the likelihood of developing obesity related
complications. Odds ratios in the group with the highest BMI of
the sample varied between 1.6 and 2.8 conditional on their W:
H-R. Patients with a medium BMI but high W:H-R had a higher
relative risk (odds ratio 1.8) than patients with a high BMI but
